Saving changes...

Done

Error

Melanoma Diagnosis and Management Considerations

Melanoma Diagnosis and Management Considerations

Melanoma Diagnosis and Management Considerations

Megan Brafford May, Pharm.D., BCOP
Megan Brafford May, Pharm.D., BCOP
on behalf of ProCE Inc.

FREE
FREE
FREE

FREE
FREE
FREE

null FREE
FREE
FREE
null FREE
FREE
FREE
Normal Price: FREE FREE

Review:

Launch date: 08 Mar 2017
Expiry Date:

Last updated: 13 Mar 2017

Reference: 170946

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

Melanoma is the deadliest of all the skin cancers. Its prevalence continues to grow year after year. The risk of melanoma increases with age, but is now occurring more frequently in younger patients. It is estimated that in 2016 over 76,000 new cases of Melanoma were diagnosed leading to over 10,000 deaths from this disease. This puts melanoma in the top ten list of cancers for men and women in the United States. This educational activity will provide an overview of the diagnosis, epidemiology, risk factors, pathology, and staging of melanoma. This activity will include an in-depth review of treatments for melanoma. Adverse events, appropriate patient monitoring, and adherence will also be discussed.

Objectives

Objectives
Learning Objectives:The target audience for this activity includes pharmacists. Upon completion of this activity, participants will be able to:Describe the epidemiology, pathophysiology, and risk factors associated with melanoma.Discuss the screening, diagnosis, and staging of melanoma.Outline treatment considerations and the mechanism of action of chemotherapy and supportive therapies.Describe the side effect and monitoring parameters associated with therapies managed through specialty pharmacy.Discuss counseling strategies to maximize compliance and adherence.
Megan Brafford May, Pharm.D., BCOP

Author Information Play Video Bio

Megan Brafford May, Pharm.D., BCOP
on behalf of ProCE Inc.

Megan Brafford May, Pharm.D., BCOP Clinical Oncology Pharmacy Specialist Baptist Health Lexington Lexington, KY

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.00 Hours -
    Exam Pass Rate: 75
    -
    Reference: 0221-9999-17-098-H01-P

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error